| Literature DB >> 29463198 |
Axel Colling1,2,3,4,5,6, Ross Lunt1,2,3,4,5,6, Jemma Bergfeld1,2,3,4,5,6, Leanne McNabb1,2,3,4,5,6, Kim Halpin1,2,3,4,5,6, Susan Juzva1,2,3,4,5,6, Kim Newberry1,2,3,4,5,6, Chris Morrissy1,2,3,4,5,6, Cameron Loomes1,2,3,4,5,6, Simone Warner1,2,3,4,5,6, Ibrahim Diallo1,2,3,4,5,6, Peter Kirkland1,2,3,4,5,6, Christopher C Broder1,2,3,4,5,6, Gemma Carlile1,2,3,4,5,6, Mai Hlaing Loh1,2,3,4,5,6, Caryll Waugh1,2,3,4,5,6, Lynda Wright1,2,3,4,5,6, James Watson1,2,3,4,5,6, Debbie Eagles1,2,3,4,5,6, Kurt Zuelke1,2,3,4,5,6, Sam McCullough1,2,3,4,5,6, Peter Daniels1,2,3,4,5,6.
Abstract
Obtaining statistically sound numbers of sera from Hendra virus (HeV)-infected horses is problematic because affected individuals usually die or are euthanized before developing a serum antibody response. As a consequence, test validation becomes a challenge. Our approach is an extension of OIE principles for provisional recognition and included 7 validation panels tested across multiple laboratories that provided estimates for test performance characteristics. At a 0.4 S/P cutoff, 16 of 19 sera from HeV-infected horses gave positive results in the HeV soluble G, indirect ELISA (HeVsG iELISA; DSe 84.2% [95% CI: 60.4-96.6%]); 463 of 477 non-infected horse sera tested negative (DSp 97.1% [95% CI: 95.1-98.4%]). The HeVsG iELISA eliminated almost all false-positive results from the previously used HeV iELISA, with marginally decreased relative sensitivity. Assay robustness was evaluated in inter-laboratory and proficiency testing panels. The HeVsG iELISA is considered to be fit for purpose for serosurveillance and international movement of horses when virus neutralization is used for follow-up testing of positive or inconclusive serum samples.Entities:
Keywords: Hendra virus serology; horses; network; sensitivity; specificity; validation
Mesh:
Substances:
Year: 2018 PMID: 29463198 PMCID: PMC6505820 DOI: 10.1177/1040638718760102
Source DB: PubMed Journal: J Vet Diagn Invest ISSN: 1040-6387 Impact factor: 1.279